Cinctive Capital Management LP Novo Cure LTD Transaction History
Cinctive Capital Management LP
- $1.86 Billion
- Q4 2024
A detailed history of Cinctive Capital Management LP transactions in Novo Cure LTD stock. As of the latest transaction made, Cinctive Capital Management LP holds 109,812 shares of NVCR stock, worth $2.35 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
109,812Holding current value
$2.35 Million% of portfolio
0.18%Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
271Shares Held
73.8MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$259 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$252 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$169 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$92.1 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$60 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.24B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...